Effect of Selenium versus N-acetyl cysteine on Oxidative Stress and Clinical Outcome of Idiopathic Pulmonary Fibrosis patients: a randomized controlle

Effect of Selenium versus N-acetyl cysteine on Oxidative Stress and Clinical Outcome of Idiopathic Pulmonary Fibrosis patients: a randomized controlled study Selenium in Idiopathic Pulmonary Fibrosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201610001800151

Enrollment

Registered

2016-10-02

Start date

2012-04-03

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Idiopathic Pulmonary Fibrosis

Interventions

selenium

Healthy Volunteers

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients were included if they proved to be in idiopathic pulmonary fibrosis as diagnosed by HRCT according to official ATS/ERS Statement3 signed an informed consent.

Exclusion criteria

Exclusion criteria: in acute exacerbation of IPF, with known cause of interstitial lung disease, allergic to selenium, renally impaired, pregnant or breast-feeding, on mechanical ventilation or on other antioxidants

Design outcomes

Primary

Measure	Time frame
to evaluate the efficacy, safety and tolerability of oral selenium administration in addition to conventional therapy in patients with IPF	—

Secondary

Measure	Time frame
assessment of IPF patients¿ clinical outcome	—

Countries

Egypt

Contacts

Public ContactNada Farrag

Responsible for all public relations

Nada_hazem87@hotmail.com00201002092625

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026